# MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)

> **NCT04572256** · EARLY_PHASE1 · RECRUITING · sponsor: **Austin V Stone** · enrollment: 30 (estimated)

## Conditions studied

- ACL Injury
- Meniscus Tear
- Post-traumatic Osteoarthritis

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04572256
- **Lead sponsor:** Austin V Stone
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04572256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04572256, "MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04572256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*